Results

Total Results: 53 records

Showing results for "blood stool".

21. Archived: Colorectal Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening-2002
    June 13, 2002 - methods of FOBT screening use guaiac-based test cards prepared at home by patients from three consecutive stool … Neither digital rectal examination (DRE) nor the testing of a single stool specimen obtained during DRE … There is little evidence to determine the effectiveness of either DRE or a single office FOBT using a stool … screening. 8 Samples collected by DRE may be affected by other limitations, including inadequate amount of stool … Tests that incorporate quantitative measures of heme and genetic stool markers have not been evaluated

22. Screening for Colorectal Cancer (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/4Y3fahSbgS2CJaj9HmJTYe
    November 23, 2020 - The two types of tests recommended by the USPSTF include: • Stool-based tests are generally used every … These test the person’s stool for signs of colorectal cancer. … Examples of these types of tests include high-sensitivity fecal occult blood tests, fecal immunochemical … tests, and stool DNA tests. • Direct visualization tests are generally used every 5 to 10 years.

23. Draft Research Plan: Helicobacter Pylori Infection: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/heliobacter-pylori-infection-screening
    November 17, 2022 - Screening interventions Screening tests for detecting H. pylori infection (e.g., urea breath; stool … antigen; stool PCR; blood antibody; urine antibody; endoscopic biopsy)   Treatment interventions

24. Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/6hyj7-3s6Qxs-brqhxPVxD
    June 06, 2017 - colonoscopy, flexible sigmoidoscopy, computed tomography colonography, the guaiac-based fecal occult blood … DNA test; gFOBT, guaiac-based fecal occult blood test; RCT, randomized clinical trial. … ; gFOBT, guaiac-based fecal occult blood test; USPSTF, US Preventive Services Task Force. … Serology Tests The FDA approved a blood test to detect circulating methylated SEPT9 DNA(EpiproColon … test; Colonoscopy every 10 ya 24 22 24 HSgFOBT, high-sensitivity guaiac-based fecal occult blood test

25. Archived: Colorectal Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening-june-2016
    June 15, 2016 - Multiple randomized clinical trials (RCTs) have shown that screening with the guaiac-based fecal occult blood … Serology Tests The FDA approved a blood test to detect circulating methylated SEPT9 DNA (Epi proColon … Multitarget stool DNA testing for colorectal-cancer screening. … DNA test; gFOBT=guaiac-based fecal occult blood test; RCT=randomized clinical trial. … guaiac-based fecal occult blood test.

26. Archived: Colorectal Cancer: Screening, 1996 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening-1996
    January 01, 1996 - asymptomatic persons are 26-92% and 90-99%, respectively (usually based on two samples from three different stool … acid and other antioxidants that interfere with test reagents, 16 and extended delay before testing stool … HemoQuant (SmithKline Diagnostics, Sunnyvale, CA), a quantitative measurement of hemoglobin in the stool … False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). … A mass screening program for colorectal cancer using chemical testing for occult blood in the stool.

27. Final Research Plan: Colorectal Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan54/colorectal-cancer-screening
    April 17, 2014 - Computed tomography (CT) colonography Fecal screening tests: Guaiac fecal occult blood … test (gFOBT) Fecal immunochemical test (FIT) Fecal DNA test Blood screening … screening tests: High-sensitivity gFOBT FIT Fecal DNA test Blood … as gFOBT (e.g., Hemoccult SENSA®), FIT (quantitative and qualitative testing), and fecal DNA test; blood … KQs 2–3: Hemoccult II (review of test performance and harms limited to high-sensitivity gFOBT); stool

28. Archived: Final Research Plan: Colorectal Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan54/colorectal-cancer-screening-june-2016
    April 17, 2014 - Computed tomography (CT) colonography Fecal screening tests: Guaiac fecal occult blood … test (gFOBT) Fecal immunochemical test (FIT) Fecal DNA test Blood screening … screening tests: High-sensitivity gFOBT FIT Fecal DNA test Blood … as gFOBT (e.g., Hemoccult SENSA®), FIT (quantitative and qualitative testing), and fecal DNA test; blood … KQs 2–3: Hemoccult II (review of test performance and harms limited to high-sensitivity gFOBT); stool

29. Modeling Study: Colorectal Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-modeling-study18/colorectal-cancer-screening
    May 18, 2021 - 50, or 55 years to ages 70, 75, 80, or 85 years with fecal immunochemical testing (FIT), multitarget stool … FIT and sDNA-FIT were grouped together as exclusively stool-based modalities with comparable burden. … Of the 16 efficient stool-based strategies, 11were those with FIT ( Table 3 , Figure 3 ), including … Outcomes at repeated rounds of stool testing have been reported in 2 small studies; 33 , 34 findings … The cumulative risk of false-positive fecal occult blood test after 10 years of colorectal cancer screening

30. Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/473PPVwoRhapCkN9SC-rue
    May 18, 2021 - 50, or 55 years to ages 70, 75, 80, or 85 years with fecal immunochemical testing (FIT), multitarget stool … RELEVANCE This microsimulation modeling analysis suggests that screening for colorectal cancer with stool … FIT and sDNA-FIT were grouped together as exclusively stool- based modalities with comparable burden. … g The lack of specificity with CTC reflects detection of nonadenomatous lesions �6 mm, artifacts, stool … The cumulative risk of false-positive fecal occult blood test after 10 years of colorectal cancer screening

31. Archived: Obesity in Children and Adolescents: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/obesity-in-children-and-adolescents-screening-june-2017
    June 20, 2017 - obesity is associated with poor cardiovascular and metabolic outcomes during childhood (e.g., high blood … Pooled reductions in systolic blood pressure (6 studies; pooled mean difference in change between groups … , -6.4 mm Hg [95% CI, -8.6 to -4.2]; I 2 =51%) and diastolic blood pressure (6 studies; pooled mean … Trials showed no benefit on blood pressure or lipid levels and a small benefit on insulin or glucose … 70% of participants taking orlistat and 0% to 8% of those taking placebo, and uncontrolled passage of stool

32. Screening for Obesity in Children and Adolescents: Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/DMDPeSf_nEUM-HrVrX6c7U
    June 20, 2017 - obstructive sleep apnea, orthopedic problems, and adverse cardiovascular and metabolic outcomes (eg, high blood … Pooled re­ ductions in systolic blood pressure (6 studies; pooled mean difference in change between … groups, −6.4 mm Hg [95% CI, −8.6 to −4.2]; I2 = 51%) and diastolic blood pressure (6 studies; pooled … Trials showed no benefit on blood pressure or lipid levels and a small benefit on insulin or glucose … of participants taking orlistat and 0% to 8% of those taking placebo, and uncontrolled passage of stool

33. Screening for Colorectal Cancer: A Targeted, Updated Systematic Review (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/UCajZVxQEKLCgs59HV7ddE
    November 01, 2008 - testing done only in subsample based on histopathologic and colonoscopic results (n � 2507) Whole-stool … Flythrough 3D imaging with 2D correlation of abnormality (Viatronix V3D 1.2, Stony Brook, New York); stool … and of stool, and colonoscopy were recently published (Ahlquist DA, et al. … Mutant-enriched PCR and allele-specific hybridization reaction to detect K-ras mutations in stool DNA … Decision Memo for Screening DNA Stool Test for Colorectal Cancer (CAG-00144N).

34. Archived: Final Evidence Summary: Colorectal Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary4/colorectal-cancer-screening-2008
    October 15, 2008 - Mutant-enriched PCR and allele-specific hybridization reaction to detect K -ras mutations in stool DNA … Immunochemical versus guaiac fecal occult blood tests. … [PMID: 15616212] Decision Memo for Screening DNA Stool Test for Colorectal Cancer (CAG-00144N). … subsample based on histopathologic and colonoscopic results ( n = 2507) Hemoccult II Whole-stool … and of stool, and colonoscopy were recently published (Ahlquist DA, et al.

35. Archived: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication, 1996 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-prophylaxis-myocardial-infarction-preventive-medication-1996
    January 01, 1996 - The principal risk factors for coronary heart disease are smoking, high blood pressure, elevated serum … to dyspepsia or constipation, 3.6% experienced bleeding or bruising, and 2.2% had gastrointestinal blood … reported little difference in epigastric discomfort, decreased hemoglobin concentration, or occult blood … in stool in persons receiving 325 mg/day. 10 There are no randomized controlled trials that assess … recommends that physicians discuss aspirin prophylaxis with men who have risk factors for MI (e.g., high blood

36. Archived: Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication
    March 15, 2009 - cvdrisk.nhlbi.nih.gov/calculator.asp For women: Risk factors for ischemic stroke include age, high blood … risk factors: age, diabetes, total cholesterol levels, high-density lipoprotein cholesterol levels, blood … Risk factors for stroke include age, high blood pressure, diabetes, smoking, a history of cardiovascular … , bright red blood per rectum, syncope, and lightheadedness). … This tool uses sex, age, smoking, diabetes, blood pressure, and cholesterol levels as risk factors for

37. Archived: Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication-2009
    March 15, 2009 - cvdrisk.nhlbi.nih.gov/calculator.asp For women: Risk factors for ischemic stroke include age, high blood … risk factors: age, diabetes, total cholesterol levels, high-density lipoprotein cholesterol levels, blood … Risk factors for stroke include age, high blood pressure, diabetes, smoking, a history of cardiovascular … , bright red blood per rectum, syncope, and lightheadedness). … This tool uses sex, age, smoking, diabetes, blood pressure, and cholesterol levels as risk factors for

38. Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/UPu84CV2CNuxR8kpVU6e3V
    November 01, 2008 - and we did not include newer screen- ing tests, such as computed tomographic colonography or the DNA stool … Reducing mortality from colorectal cancer by screening for fecal occult blood. … Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. … The effect of fecal occult-blood screening on the incidence of colorectal cancer. … Cost-effectiveness of DNA stool testing to screen for colo- rectal cancer: report to AHRQ and CMS from

39. Archived: Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force: Colorectal Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evaluating-test-strategies-for-colorectal-cancer-screening-a-decision-analysis-for-the-us-preventive-services-task-force/colorectal-cancer-screening-2008
    October 15, 2008 - and we did not include newer screening tests, such as computed tomographic colonography or the DNA stool … Reducing mortality from colorectal cancer by screening for fecal occult blood. … Randomised study of screening for colorectal cancer with faecal-occult-blood test. … The effect of fecal occult-blood screening on the incidence of colorectal cancer. … Cost-effectiveness of DNA stool testing to screen for colorectal cancer: report to AHRQ and CMS from

40. Aspirin for the Prevention of Cardiovascular Disease: Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Q4J7tsThw_6nwfB-p-f5Hp
    March 01, 2009 - risk factors: age, diabetes, total cholesterol levels, high-density lipoprotein cholesterol levels, blood … , bright red blood per rectum, syncope, and lightheadedness). … on screen- ing for abdominal aortic aneurysm, carotid artery stenosis, coronary heart disease, high blood … This tool uses sex, age, smoking, diabetes, blood pres- sure, and cholesterol levels as risk factors … Gastrointes- tinal bleeding, peptic ulcers, self-reported hematuria (blood in the urine), easy bruising